Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Vitamin D and Diabetes

  1. Teresa Martin, RD, CDE, LD and
  2. R. Keith Campbell, RPh, CDE, FASHP
Diabetes Spectrum 2011 May; 24(2): 113-118. https://doi.org/10.2337/diaspect.24.2.113
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Renewed interest in vitamin D, the so-called “sunshine vitamin,” has occurred recently because it has been linked to everything from cancer and heart disease to diabetes.1 Research studies continue to pour into the literature stating that vitamin D is a superstar when it comes to health. However, most of the research is based on observational, epidemiological studies, which are important for generating hypotheses but do not prove causality.

A PubMed search in 2011 using the term “vitamin D” and selecting articles published in the past 2 years resulted in more than 2,864 hits. The following diseases and conditions have been researched to assess their relationship with vitamin D status: osteomalacia/osteoporosis,2–5 muscle function and falls,6–8 cancer,9–14 multiple sclerosis,15 hypertension,16 type 1 diabetes,17 rheumatoid arthritis,18 tuberculosis,19,20 mental health,21 cardiovascular events,22,23 infection,24,25 seasonal affective disorder,26 obesity,27 aging,28 and overall mortality.23

The challenge for health care providers and nutrition researchers is to determine whether vitamin D deficiency actually causes or increases the incidence of certain diseases or whether, instead, low levels of vitamin D are simply coincidental given that the majority of the general population, regardless of disease, is likely to have insufficient levels of vitamin D. In other words, do people who develop disease states just happen to be deficient in vitamin D, or do low levels of vitamin D cause the disease? Will supplementation with vitamin D prevent diseases, and can it be used to treat diseases such as diabetes?

The purpose of this article is to summarize the latest information related to diabetes and vitamin D. For readers who desire further information, Holick29 has written extensively about the high prevalence of vitamin D deficiency and its implications for health. There is also an excellent recent review of vitamin D insufficiency by Thatcher and Clarke.1

Clinical Understanding of Vitamin D

There are two main forms of vitamin D: ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). Vitamin D2 is synthesized by plants (mainly mushrooms and yeast), whereas vitamin D3 is synthesized in skin when it is exposed to ultraviolet B rays from sunlight. Vitamin D3 is also found in a few foods such as fatty fish.30

Unfortunately, it is very difficult to get enough vitamin D from food sources alone. Both vitamin D2 and vitamin D3 can be made synthetically and are used to fortify foods such as milk products, margarine, and soy milk and to make dietary supplements. The synthetic form of vitamin D3 is derived from animal sources and is currently the most common form of vitamin D used in supplements and fortified foods.31

The dietary forms of vitamin D are absorbed in the small intestine with dietary fats and other fat-soluble vitamins, whereas vitamin D3 enters circulation after it is synthesized nonenzymatically in the skin during exposure to the ultraviolet rays in sunlight. Neither vitamin D2 nor vitamin D3 have any biological functions in the body until they go through a two-step process of metabolism.2 The metabolism of the various forms of vitamin D requires conversion in the liver and kidney, and the active form, 1,25-dihydroxyvitamin D (calcitriol), needs to bind to vitamin D receptors (VDRs) before biological actions occur.32,33 Thus, diabetic patients with liver or kidney problems are at high risk of deficiency, as are patients with gastrointestinal disorders such as celiac disease, pancreatitis, low bile levels, or sprue.34

In the past, the major source of vitamin D for humans was exposure to sunlight. One possible cause of the current widespread vitamin D deficiency is the lack of sunlight exposure. Another possible cause is a lack of dietary sources of vitamin D.32

Since the industrial revolution, very few people get much sun exposure while working. Other barriers to sunshine exposure include fear of skin cancer, which has led to an increased use of sunscreen, hats, and other sun barriers. For some people, religious beliefs require that their skin be covered. Environmental factors such as pollution and fewer hours of sun exposure during the winter (especially in latitudes north of ∼ 37°) also decrease vitamin D synthesis from sunlight exposure.35 Additionally, aging skin and skin of darker color require longer exposure to sunlight to initiate vitamin D synthesis.34

It has been suggested that ∼ 5–30 minutes of sun exposure between 10:00 a.m. and 3:00 p.m. at least twice per week on the skin of the face, arms, back, or legs (without sunscreen) is usually adequate for vitamin D synthesis.2,36 Skin exposed to sunshine indoors, as through a glass window, will not produce vitamin D.37

The most accurate way to determine vitamin D status is to measure 25-hydroxy vitamin D [(25(OH)D)]. The optimal range is 25–80 ng/ml. However, normal value ranges may vary slightly among different laboratories.38 Table 1 lists categories of vitamin D status based on 25(OH)D measurement.

The Food and Nutrition Board of the Institute of Medicine (IOM) recently updated the Dietary Reference Intake (DRI) for vitamin D.39 The IOM recommends 600 IU/day of vitamin D for individuals aged 9–70 years and 800 IU/day for those > 70 years of age.40 However, others recommend that supplementation with vitamin D3 should be prescribed with the objective of achieving a serum 25(OH)D level of at least 40 ng/ml and possibly even 60 ng/ml.40 Table 2 lists the new DRIs for vitamin D.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Categorization of Vitamin D Levels38

Treatment of Vitamin D Deficiency

The two forms of vitamin D supplements are D2 (ergocalciferol) and D3 (cholecalciferol). Both increase vitamin D in the blood. Vitamin D supplements are readily available, inexpensive, easy to administer, and safe. At high doses, vitamin D2 may be less potent than vitamin D3.37 The safe upper limit for vitamin D is 1,000–1,500 IU/day for infants, 2,500–3,000 IU/day for children aged 1–8 years, and 4,000 IU/day for children ≥ 9 years of age, adults, and pregnant and lactating teens and women.39

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Current DRI Recommendations for Vitamin D39

Although levels of supplementation used in practice vary among practitioners, recommendations do exist within the literature. One group41 recommends the following for vitamin D repletion: 1,000 IU/day of vitamin D3 if 25(OH)D is 30–40 ng/ml, 2,000 IU/day of vitamin D3 if 25(OH)D is 20–30 ng/ml, and, for adults with serum levels < 20 ng/ml, prescribe 50,000 IU of vitamin D2 once to three times per week for 4 weeks followed by 3,000 IU/day until serum 25(OH)D levels are > 30 ng/ml. Then, recheck serum 25(OH)D levels 3–6 months later, and continue treating until serum levels are > 40 ng/ml.

Some experts have found that between 2,000 and 4,000 IU/day of vitamin D3 is necessary to reduce the risks of cancer and autoimmune disease and therefore recommend these higher doses for patients with these specific disease states.42 Experts also recommend supplementing infants and children with at least 400 IU/day of vitamin D3, especially infants who are breastfed.34

Controversy often follows recommendations related to micronutrients and disease states, and the case of vitamin D is no different. Experts from the IOM, which is an arm of the National Academy of Sciences, caution that more vitamin D is not necessarily better for all patients. The IOM concluded in its 2010 report39 that the evidence for a benefit of vitamin D in bone health is compelling, but that for other conditions such as cancer and cardiovascular disease, the evidence is inconclusive and insufficient to drive specific nutritional requirements for vitamin D intake. The report also says that cut points for testing for vitamin D levels in blood are not grounded in strong scientific evidence and that these cut points may be leading to an overestimation of the prevelance of vitamin D deficiency.39

The variance in recommendations and clinical practice has the potential to confuse patients and health care providers, but it demonstrates that there may be a wide range of dosing recommendations for vitamin D depending on a specific patient's disease-state status and level of deficiency. It is reassuring to know that vitamin D supplementation is relatively safe and that cases of toxicity are rare and have been observed only when patients are taking > 40,000 IU/day.43

The IOM recommendations hopefully will not be misinterpreted and cause people to stop taking supplements if their 25(OH)D levels are low. In addition, as was noted in the IOM report, additional research is needed regarding the role of vitamin D in various disease states, including diabetes.

Vitamin D and Diabetes

Vitamin D deficiency and diabetes have one major trait in common: both are pandemic. The International Diabetes Federation estimates the number of people with diabetes worldwide to be nearly 285 million, or 7% of the world's population.44 This number is expected to exceed 435 million by 2030.44 In the United States, an estimated 79 million people have pre-diabetes.45

Mechanisms of action

There is growing evidence that vitamin D deficiency could be a contributing factor in the development of both type 1 and type 2 diabetes. First, the β-cell in the pancreas that secretes insulin has been shown to contain VDRs as well as the 1 alpha hydroxylase enzyme.46 Evidence indicates that vitamin D treatment improves glucose tolerance and insulin resistance.47,48 Vitamin D deficiency leads to reduced insulin secretion. Supplementation with vitamin D has been shown to restore insulin secretion in animals.49 Researchers have also found an indirect effect on insulin secretion, potentially by a calcium effect on insulin secretion. Vitamin D contributes to normalization of extracellular calcium, ensuring normal calcium flux through cell membranes; therefore, low vitamin D may diminish calcium's ability to affect insulin secretion.50 Other potential mechanisms associated with vitamin D and diabetes include improving insulin action by stimulating expression of the insulin receptor, enhancing insulin responsiveness for glucose transport, having an indirect effect on insulin action potentially via a calcium effect on insulin secretion, and improving systemic inflammation by a direct effect on cytokines.50

Vitamin D and type 2 diabetes

After conducting a meta-analysis and review of the impact of vitamin D and calcium on glycemic control in patients with type 2 diabetes, Pittas et al.50 concluded that insufficient vitamin D and calcium appears to hinder glycemic control and that supplementing both nutrients may be necessary to optimize glucose metabolism. An observational study from the Nurses Health Study51 that included 83,779 women > 20 years of age found an increased risk of type 2 diabetes in those with low vitamin D status. A combined daily intake of > 800 IU of vitamin D and 1,000 mg of calcium reduced the risk of type 2 diabetes by 33%. The National Health and Nutrition Examination Survey (NHANES) III study between 1988 and 199452 demonstrated that there is a strong inverse association between low levels of 25(OH)D and diabetes prevalence. Low vitamin D levels have also been shown to be predictive of the future development of type 2 diabetes.53 One study54 showed that increasing vitamin D serum levels to normal led to a 55% relative reduction in the risk of developing type 2 diabetes. As with most disease states and vitamin D, prospective studies related to vitamin D supplementation and diabetes are rare and limited. Prospective trials of vitamin D and diabetes to date were either too small or used inadequate amounts of vitamin D.55

Kayaniyil et al.56 performed a linear regression analysis of 712 subjects after evaluating serum 25(OH)D levels and assessing insulin sensitivity by means of the homeostasis model of insulin resistance. Their results indicated that vitamin D was significantly correlated to insulin resistance and β-cell function in their multiethnic sample. The researchers concluded that low vitamin D levels may play a significant role in the pathogenesis of type 2 diabetes.

The NHANES group (2003–2006) evaluated 9,773 U.S. adults > 18 years of age and showed a mechanistic link between serum vitamin D levels, glucose homeostasis, and the evolution of diabetes.57 Based on their own study, Kositsawat et al.58 concluded that patients with elevated A1C levels should be evaluated for vitamin D insufficiency.

Vitamin D and type 1 diabetes

Observational studies also suggest that low vitamin D status may be associated with an increased risk of type 1 diabetes. For example, there is a greater incidence of type 1 diabetes related to geographic variation, with locations at higher latitudes having more type 1 diabetes. This may be the result of less sunshine and, therefore, lower levels of vitamin D.59

Hypponen et al.60 conducted a cohort study in northern Finland. They collected data during 1 year on 10,821 children regarding vitamin D supplementation dose and presence of suspected rickets as it related to the development of type 1 diabetes. Their findings were both significant and astounding; children who took 2,000 IU of vitamin D daily were 80% less likely to develop type 1 diabetes. This suggests that it may be crucial for all children to take vitamin D supplementation during their first year of life to help avoid the development of type 1 diabetes.

Another vitamin D study conducted by Zipitis et al.61 demonstrated that vitamin D supplementation in early childhood decreased the risk of developing type 1 diabetes by 29% compared to children who were not given vitamin D supplements. In addition, the researchers found evidence suggestive of a dose-response effect.

Because destruction of β-cells usually begins in infancy or early childhood and continues until type 1 diabetes is diagnosed, studies such as these are intriguing in terms of the utility of vitamin D in people with type 1 diabetes. It is hoped that starting vitamin D supplementation soon after birth may be a protective strategy against the development of type 1 diabetes.34

Another area of interest is vitamin D status during pregnancy and lactation and whether a pregnant woman's vitamin D status plays a role in the development of diabetes in her child. Gregory et al.62 suggest that pregnant women and nursing mothers should take supplements to make sure their vitamin D serum levels are optimal. This group reasoned that, because vitamin D is a powerful modulator of the immune system and helps regulate cell proliferation and differentiation, it seems clear that vitamin D could play a role in preventing type 1 diabetes. Their research showed that adequate vitamin D status in mothers did have an impact on reducing the development of type 1 diabetes in their children.

However, studies related to the precise dose and duration of vitamin D supplementation in infants and children are lacking. Currently, 400 IU of vitamin D3 is recommended for supplementation in all infants until enough formula, milk, or other food sources are ingested to sufficiently provide 400 IU/day.63 Although it seems prudent and reasonable to supplement infants, children, and adolescents with vitamin D to prevent deficiency, there is inconsistency in the recommended vitamin D dose.

Currently, evidence supports that maintaining adequate vitamin D status during pregnancy, nursing, infancy, and childhood may help prevent type 1 diabetes. However, it is still unknown whether the genetics of type 1 diabetes place individuals at risk for vitamin D deficiency or whether vitamin D deficiency places individuals at risk for type 1 diabetes.

Also lacking are studies to support that vitamin D would improve the treatment of type 1 diabetes after diagnosis. Only a few intervention studies have examined the impact of vitamin D supplementation on reversing type 1 diabetes, and they have not been successful.62

Summary and Conclusion

Although the role of vitamin D in helping to regulate blood glucose remains poorly understood, vitamin D status appears to play a role in the development and treatment of diabetes. It is possible that optimal levels of serum vitamin D may be different for people at risk for developing diabetes, those with diabetes, and those without diabetes. According to Danescu et al.64, “both animal and human studies support the notion that adequate vitamin D supplementation may decrease the incidence of type 1 and possibly also of type 2 diabetes mellitus and may improve the metabolic control in the diabetes state. However, the exact mechanisms are not clear and need further investigation.”

Footnotes

  • Teresa Martin, RD, CDE, LD, is a diabetes educator for Novo Nordisk based in Bend, Ore. R. Keith Campbell, RPh, CDE, FASHP, is a distinguished professor in diabetes care at Washington State University College of Pharmacy in Pullman.

  • American Diabetes Association(R) Inc., 2011

References

  1. ↵
    1. Thatcher TD,
    2. Clarke BL
    : Vitamin D insufficiency. Mayo Clinic Proc 86:50–60, 2011
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Holick MF
    : Vitamin D deficiency. N Engl J Med 357:266–281, 2007
    OpenUrlCrossRefPubMedWeb of Science
    1. Chapuy MC,
    2. Schott AM,
    3. Garnero P,
    4. Hans D,
    5. Delmas PD,
    6. Meunier J
    : Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129–1133, 1996
    OpenUrlCrossRefPubMedWeb of Science
    1. Bakhtiyarova S,
    2. Lesnyak O,
    3. Kyznesova N,
    4. Blankenstein MA,
    5. Lips P
    : Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int 17:441–446, 2006
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Larsen ER,
    2. Mosekilde L,
    3. Foldspang A
    : Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 19:370–378, 2004
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Bischoff-Ferrari HA,
    2. Dietrich T,
    3. Orav EJ,
    4. Hu FB,
    5. Zhang Y,
    6. Karlson EW,
    7. Dawson-Hughes B
    : Higher 25-hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged ≥ 60 y. Am J Clin Nutr 80:752–758, 2004
    OpenUrlAbstract/FREE Full Text
    1. Broe KE,
    2. Chen TC,
    3. Weinberg J,
    4. Bischoff-Ferrari HA,
    5. Holick MF,
    6. Kiel D
    : A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55:234–239, 2007
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Visser M,
    2. Deeg DJH,
    3. Lips P
    : Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength an muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 88:5766–5772, 2003
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Garland CF,
    2. Comstock GW,
    3. Garland FC,
    4. Helsing KJ,
    5. Shaw EK,
    6. Gorham ED
    : Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176–1178, 1989
    OpenUrlPubMedWeb of Science
    1. Gorham ED,
    2. Garland CF,
    3. Garland FC,
    4. Grant WB,
    5. Mohr SB,
    6. Lipkin M,
    7. Newmark HL,
    8. Giovannucci E,
    9. Wei M,
    10. Holick MF
    : Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97:179–194, 2005
    OpenUrlCrossRefPubMedWeb of Science
    1. Hanchette CL,
    2. Schwartz GG
    : Geographic patterns of prostate cancer mortality. Cancer 70:2861–2869, 1992
    OpenUrlCrossRefPubMedWeb of Science
    1. Grant WB
    : An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875, 2002
    OpenUrlCrossRefPubMedWeb of Science
    1. Grant WG,
    2. Garland CF
    : The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26:2687–2700, 2006
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Giovannucci E,
    2. Liu Y,
    3. Rimm EB,
    4. Hollis BW,
    5. Fuchs CS,
    6. Stampfer MJ,
    7. Willett WC
    : Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459, 2006
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Munger KL,
    2. Zhang SM,
    3. O'Reilly E,
    4. Hernan MA,
    5. Olek MJ,
    6. Willett WC,
    7. Ascherio A
    : Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60–65, 2004
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Krause R,
    2. Buhring M,
    3. Hopfenmuller W,
    4. Holick MF,
    5. Sharma AM
    : Ultraviolet B and blood pressure. Lancet 352:709–710, 1998
    OpenUrlPubMedWeb of Science
  10. ↵
    1. Hypponen E,
    2. Laara E,
    3. Jarvelin M-R,
    4. Virtanen SM
    : Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503, 2001
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Merlino LA,
    2. Curtis J,
    3. Mikuls TR,
    4. Cerhan JR,
    5. Criswell LA,
    6. Saag KG
    : Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 50:72–77, 2004
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Chan TYK
    : Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 66:476–478, 2000
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Liu PT,
    2. Stenger S,
    3. Li H,
    4. Wenzel L,
    5. Tan BH,
    6. Krutzik SR,
    7. Ochoa MT,
    8. Schauber J,
    9. Wu K,
    10. Meinken C,
    11. Kamen DL,
    12. Wagner M,
    13. Bals R,
    14. Steinmeyer A,
    15. Zugel U,
    16. Gallo RL,
    17. Eisenberg D,
    18. Hewison M,
    19. Hollis BW,
    20. Adams JS,
    21. Bloom BR,
    22. Modlin RL
    : Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 3:1770–1773, 2006
    OpenUrl
  14. ↵
    1. McGrath J,
    2. Saari K,
    3. Hakko H,
    4. Jokelainen J,
    5. Jones P,
    6. Jarvelin MR,
    7. Chant D,
    8. Isohanni M
    : Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 67:237–245, 2004
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Dobnig H,
    2. Pilz S,
    3. Scharnagl H,
    4. Renner W,
    5. Seelhorst U,
    6. Wellnitz B,
    7. Kinkeldei J,
    8. Boehm BO,
    9. Weihrauch G,
    10. Maerz W
    : Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349, 2008
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Ginde AA,
    2. Scragg R,
    3. Schwartz RS,
    4. Camargo CA Jr.
    : Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all cause mortality in older U.S. adults. J Am Geriatr Soc 57:1595–1603, 2009
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Ginde AA,
    2. Mansbach JM,
    3. Camargo CA Jr.
    : Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169:384–390, 2009
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. McNally JD,
    2. Leis K,
    3. Matheson LA,
    4. Karuananyake C,
    5. Sankaran K,
    6. Rosenberg AM
    : Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol 44:981–988, 2009
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Gloth FM III.,
    2. Alam W,
    3. Hollis B
    : Vitamin D vs. broad spectrum phototherapy in the treatment of seasonal effective disorder. J Nutr Health Aging 3:5–7, 1999
    OpenUrlPubMed
  20. ↵
    1. Wortsman J,
    2. Matsuoka LY,
    3. Chen TC,
    4. Lu Z,
    5. Holick MF
    : Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693, 2000
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Holick MF,
    2. Matsuoka LY,
    3. Wortsman J
    : Age, vitamin D, and solar ultraviolet. Lancet 2:1104–1105, 1989
    OpenUrlPubMedWeb of Science
  22. ↵
    1. Holick MF
    : High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373, 2006
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Holick MF
    : Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S–1688S, 2004
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Yetley EA
    : Vitamin D and health in the 21st century: an update assessing the vitamin D status of the US population. Am J Clin Nutr 88:558S–564S, 2008
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Holick MF
    : Vitamin D for health and in chronic kidney disease. Semin Dial 18:266–275, 2005
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Holick MF,
    2. Chen TC
    : Vitamin D deficiency: a worldwide problem and health consequences. Am J Clin Nutr 87 (Suppl.):1080S–1086S, 2008
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Rifkin J
    : The role of vitamin D in diabetes. Pract Diabetol 28:5–8, 2009
    OpenUrl
  28. ↵
    1. Tsiaras WG,
    2. Weinstock MA
    : Factors influencing vitamin D status. Acta Derm Venereol 91:115–124, 2011
    OpenUrlPubMedWeb of Science
  29. ↵
    1. Holick MF
    : Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9:87–98, 2002
    OpenUrlCrossRef
  30. ↵
    Office of Dietary Supplements, National Institutes of Health: Dietary supplement fact sheet: vitamin D [article online]. Available from http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Accessed 25 March 2011
  31. ↵
    Mayo Medical Laboratories: Vitamin D testing [article online]. Available from http://www.mayomedicallaboratoires.com/articles/vitamind/index.html. Accessed 25 March 2011
  32. ↵
    Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, D.C., National Academy Press, 2010
  33. ↵
    1. Binkley N
    : Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 92:21–30, 2007
    OpenUrl
  34. ↵
    1. Pepper KJ,
    2. Judd SE,
    3. Nanes MS,
    4. Tangpricha V
    : Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 15:95–103, 2009
    OpenUrlPubMed
  35. ↵
    1. DeLuca H
    : Evolution of our understanding of vitamin D. Nutr Rev 66 (Suppl. 2):S73–S87, 2008
    OpenUrlCrossRefPubMed
  36. ↵
    1. Veith R,
    2. Pinto TR,
    3. Reen BS,
    4. Wong MM
    : Vitamin D poisoning by table sugar. Lancet 359:672, 2002
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    International Diabetes Federation: IDF Diabetes Atlas, 2009 [article online]. Available from www.eatlas.idf.org. Accessed 25 March 2011
  38. ↵
    Centers for Disease Control and Prevention: 2011 National diabetes fact sheet [article online]. Available from http://www.cdc.gov/diabetes/pubs/factsheet11.htm. Accessed 25 March 2011
  39. ↵
    1. Bland R,
    2. Markovic D,
    3. Hills CE,
    4. Hughes SV
    : Expression of 25-hydroxyvitamin D3-1 alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 121:89–90, 2004
    OpenUrl
  40. ↵
    1. Parekh D,
    2. Sarathi V,
    3. Shivane VK,
    4. Bandgar TR,
    5. Menon PS,
    6. Shah NS
    : Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes. Endocr Pract 16:600–608, 2010
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Von Hurst PR,
    2. Sonehouse W,
    3. Coad J
    : Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient: a randomized, placebo-controlled trial. Br J Nutr 103:549–555, 2010
    OpenUrlCrossRefPubMed
  42. ↵
    1. Bourlon PM,
    2. Billaudel B,
    3. Faure-Dussert A
    : Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160:87–95, 1999
    OpenUrlAbstract
  43. ↵
    1. Pittas AG,
    2. Lau J,
    3. Hu FB,
    4. Dawson-Hughes B
    : The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endo Metab 92:2017–2029, 2007
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Pittas AG,
    2. Dawson-Hughes B,
    3. Li T,
    4. Van Dam RM,
    5. Willett WC,
    6. Manson JE,
    7. Hu FB
    : Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650–656, 2006
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Scragg R,
    2. Sowers MF,
    3. Bell C
    : Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third National Health and Nutrition Examination Survey. Diabetes Care 27:2813–2818, 2004
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Forouohi NG,
    2. Luan J,
    3. Cooper A,
    4. Boucher BJ,
    5. Wareham NJ
    : Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely prospective study, 1990–2000. Diabetes 57:2619–2625, 2008
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Parker J,
    2. Hashmi O,
    3. Dutton D,
    4. Mavrodaris A,
    5. Stranges S,
    6. Kandala NB,
    7. Clarke A,
    8. Franco OH
    : Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65:225–236, 2010
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Schwallenberg G
    : Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion. Can Fam Phys 54:864–866, 2008
    OpenUrlFREE Full Text
  49. ↵
    1. Kayaniyil S,
    2. Vieth R,
    3. Retnakaran R,
    4. Knight JA,
    5. Qi Y,
    6. Gerstein HC,
    7. Perkins BA,
    8. Harris SB,
    9. Zinman B,
    10. Hanley AJ
    : Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33:1379–1381, 2010
    OpenUrlAbstract/FREE Full Text
  50. ↵
    U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey data: survey operations manuals, brochures, and consent documents: 2003–2006 [article online]. Available from http://www.cdc.gov/nchs/nhanes.htm. Accessed 25 March 2011
  51. ↵
    1. Kositsawat J,
    2. Gerber BS,
    3. Freeman VL,
    4. Geraci S
    : Association of A1C levels with vitamin D status in U.S. adults. Diabetes Care 33:1236–1238, 2010
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Mohr SB,
    2. Garland CF,
    3. Gorham ED,
    4. Garland FC
    : The association between ultraviolet B irradiance, vitamin D status, and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398, 2008
    OpenUrlCrossRefPubMedWeb of Science
  53. ↵
    1. Hypponen E,
    2. Laara E,
    3. Reunanen A,
    4. Jarvelin MR,
    5. Virtanen SM
    : Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 358:1500–1503, 2001
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Zipitis CS,
    2. Akobeng AK
    : Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517, 2008
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. Gregory JM,
    2. Lilley JS,
    3. Misfeldt AA,
    4. Buscariollo DL,
    5. Russell WE,
    6. Moore DJ
    : Incorporating type 1 diabetes prevention into clinical practice. Clinical Diabetes 28:61–70, 2010
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Wagner CL,
    2. Greer FR
    , American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition: Prevention of rickets and vitamin D deficient in infants, children, and adolescents. Pediatrics 122:1142–1152, 2008
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Danescu LG,
    2. Levy S,
    3. Levy J
    : Vitamin D and diabetes mellitus. Endocr 35:11–17, 2009
    OpenUrl
View Abstract
PreviousNext
Back to top
Diabetes Spectrum: 24 (2)

In this Issue

May 2011, 24(2)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Vitamin D and Diabetes
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Vitamin D and Diabetes
Teresa Martin, R. Keith Campbell
Diabetes Spectrum May 2011, 24 (2) 113-118; DOI: 10.2337/diaspect.24.2.113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Vitamin D and Diabetes
Teresa Martin, R. Keith Campbell
Diabetes Spectrum May 2011, 24 (2) 113-118; DOI: 10.2337/diaspect.24.2.113
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical Understanding of Vitamin D
    • Treatment of Vitamin D Deficiency
    • Vitamin D and Diabetes
    • Mechanisms of action
    • Vitamin D and type 2 diabetes
    • Vitamin D and type 1 diabetes
    • Summary and Conclusion
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Finding My Diabetes Community
Show more Departments

Pharmacy and Therapeutics

  • Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report
  • Injection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide
  • Glucagon Therapy: A Comparison of Current and Novel Treatments
Show more Pharmacy and Therapeutics

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.